Needle-free Drug Delivery Devices Market Forecast 2020-2024 - Covid-19 Impact and Global Analysis – by Product and by Geography | Technavio

LONDON--(BUSINESS WIRE)--Nov 30, 2020--

The needle-free drug delivery devices market is poised to grow by USD 10.23 billion during 2020-2024, progressing at a CAGR of over 4% during the forecast period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201130005486/en/

Technavio has announced its latest market research report titled Global Needle-free Drug Delivery Devices Market 2020-2024 (Graphic: Business Wire)

Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.

Get FREE Sample Report in Minutes!

The report on the needle-free drug delivery devices market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by technological advances in needle-free drug delivery devices.

The needle-free drug delivery devices market analysis includes product segment and geography landscape. This study identifies the increasing government initiatives as one of the prime reasons driving the needle-free drug delivery devices market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The needle-free drug delivery devices market covers the following areas:

Needle-free Drug Delivery Devices Market Sizing

Needle-free Drug Delivery Devices Market Forecast

Needle-free Drug Delivery Devices Market Analysis

Companies Mentioned

  • 3M Co.
  • Antares Pharma Inc.
  • Becton
  • Dickinson and Co.
  • Enesi Pharma Ltd.
  • GlaxoSmithKline Plc
  • Inovio Pharmaceuticals Inc.
  • Mylan NV
  • Novartis AG
  • PharmaJet Inc.
  • and Valeritas Holdings Inc.

Related Reports onHealth CareInclude:

Global Programmable Infusion Pumps Market: The global programmable infusion pumps market size has the potential to grow by USD 487.81 million during 2020-2024. The market’s growth momentum will accelerate throughout the forecast period because of the steady increase in year-over-year growth. To get extensive research insights: Click and Get FREE Sample Report in Minutes!

Global ENT Disorder Treatment Market: The ENT disorder treatment market size has the potential to grow by USD 1.32 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. To get extensive research insights: Click and Get FREE Sample Report in Minutes!

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Value chain analysis
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Inhalers - Market size and forecast 2019-2024
  • Transdermal patches - Market size and forecast 2019-2024
  • Jet injectors - Market size and forecast 2019-2024
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Technological advances in needle-free drug delivery devices
  • Research and funding for development of needle-free drug delivery devices
  • Increasing government initiatives

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • 3M Co.
  • Antares Pharma, Inc.
  • Becton, Dickinson and Co.
  • Enesi Pharma Ltd.
  • GlaxoSmithKline Plc
  • Inovio Pharmaceuticals Inc.
  • Mylan NV
  • Novartis AG
  • PharmaJet Inc.
  • Valeritas Holdings Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com:https://www.businesswire.com/news/home/20201130005486/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email:[email protected]

Website:www.technavio.com/

KEYWORD:

INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH

SOURCE: Technavio Research

Copyright Business Wire 2020.

PUB: 11/30/2020 09:59 AM/DISC: 11/30/2020 09:59 AM

http://www.businesswire.com/news/home/20201130005486/en